TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer.
Davide MelisiRocio Garcia-CarboneroTeresa MacarullaDenis PezetGael DeplanqueMartin FuchsJorg TrojanMark KozloffFrancesca SimionatoAnn CleverlyClaire SmithShuaicheng WangMichael ManKyla E DriscollShawn T EstremMichael M F LahnKarim A BenhadjiJosep TaberneroPublished in: Cancer chemotherapy and pharmacology (2019)
Clinicaltrials.gov NCT01373164.